OTCMKTS:TXSP - Taxus Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$3.16 0.00 (0.00 %)
(As of 05/23/2018 01:26 AM ET)
Previous Close$3.16
Today's Range$3.16 - $3.16
52-Week Range$3.16 - $3.16
Volume100 shs
Average VolumeN/A
Market Capitalization$257.54 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.37

About Taxus Pharmaceuticals (OTCMKTS:TXSP)

Taxus Pharmaceuticals Holdings, Inc. is a specialty retailer. The Company sells dietary supplement products, such as vitamins, minerals, calcium, fibers and proteins, among others. The Company operates a retail store, which is located in Little Neck, New York. The Company seeks to open various retail stores in the Borough of Queens, New York City, New York.

Receive TXSP News and Ratings via Email

Sign-up to receive the latest news and ratings for TXSP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:TXSP
CUSIPN/A
WebN/A
Phone718-631-1522

Debt

Debt-to-Equity RatioN/A
Current Ratio0.15
Quick Ratio0.15

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales25,754.00
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-110,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-1,095.82%

Miscellaneous

EmployeesN/A
Outstanding Shares81,500,000

Taxus Pharmaceuticals (OTCMKTS:TXSP) Frequently Asked Questions

What is Taxus Pharmaceuticals' stock symbol?

Taxus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "TXSP."

When is Taxus Pharmaceuticals' next earnings date?

Taxus Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, May, 29th 2018. View Earnings Estimates for Taxus Pharmaceuticals.

Who are some of Taxus Pharmaceuticals' key competitors?

Who are Taxus Pharmaceuticals' key executives?

Taxus Pharmaceuticals' management team includes the folowing people:
  • Jiayue Zhang, President, Chief Executive Officer, Chief Financial Officer, Director (Age 57)

Has Taxus Pharmaceuticals been receiving favorable news coverage?

Media stories about TXSP stock have trended somewhat positive on Wednesday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Taxus Pharmaceuticals earned a coverage optimism score of 0.18 on Accern's scale. They also gave news articles about the company an impact score of 45.53 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Taxus Pharmaceuticals?

Shares of TXSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Taxus Pharmaceuticals' stock price today?

One share of TXSP stock can currently be purchased for approximately $3.16.

How big of a company is Taxus Pharmaceuticals?

Taxus Pharmaceuticals has a market capitalization of $257.54 million and generates $10,000.00 in revenue each year.

How can I contact Taxus Pharmaceuticals?

Taxus Pharmaceuticals' mailing address is 23605 BRADDOCK AVENUE, BELLEROSE NY, 11426. The company can be reached via phone at 718-631-1522.


MarketBeat Community Rating for Taxus Pharmaceuticals (TXSP)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  41
MarketBeat's community ratings are surveys of what our community members think about Taxus Pharmaceuticals and other stocks. Vote "Outperform" if you believe TXSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TXSP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Taxus Pharmaceuticals (OTCMKTS:TXSP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/23/2016 forward)

Earnings

Dividends

Taxus Pharmaceuticals (OTCMKTS:TXSP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Taxus Pharmaceuticals (OTCMKTS TXSP) Insider Trading and Institutional Ownership History

Insider Trading History for Taxus Pharmaceuticals (OTCMKTS:TXSP)

Taxus Pharmaceuticals (OTCMKTS TXSP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Taxus Pharmaceuticals (OTCMKTS TXSP) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Taxus Pharmaceuticals (OTCMKTS:TXSP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Taxus Pharmaceuticals (OTCMKTS TXSP) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.